September is Pediatric Cancer Awareness Month: spotlight on … – Examiner.com
 HealthNews |
September is Pediatric Cancer Awareness Month: spotlight on …
Examiner.com Leukemia, a blood cancer, is the most common and account for one-third of all pediatric cancers. Stem cells in the bone marrow produce white blood cells … National Childhood Cancer Awareness Month US Rep. Boswell: Investing in childhood cancer research |
 Examiner.com |
FDA to Genzyme: Cancer trial is 'insufficient'
Bizjournals.com The drug is currently approved for the treatment of pediatric-acute lymphoblastic leukemia (ALL) in patients who have relapsed or have refractory disease … FDA Panel Rejects Vion Leukemia Drug Genzyme's Woes Piling Up as FDA Panel Says Data on Leukemia Drug … FDA panel wants more data on Genzyme cancer drug |
|
Can Bone Marrow Be Quickly Revived After Destruction By Leukemia …
Science Daily (press release) In leukemia patients, cancer cells have invaded the bone marrow and physicians must kill with radiation and chemotherapy all cells in the marrow in hopes of … |
|
Trubion signs leukemia drug agreement worth up to $196M
Bizjournals.com based Facet (NASDAQ: FACT) and may get up to $176 million more for the worldwide development and commercialization of its chronic lymphocytic leukemia (CLL) … Trubion licenses drug to Facet in $196.5M deal Trubion Gets $20M Upfront in Leukemia Drug Partnership With Facet … Facet to invest in Trubion, inks drug development deal |
 WISC |
Teens, Young Adults With Leukemia Living Longer
ABC News NEW YORK (Reuters Health) – Adolescents and young adults with leukemia or lymphoma still fare worse than children with these blood cancers, … Survival Rates For Young People With Leukemia Rise Steadily Young Leukemia And Lymphoma Patients Live Longer Today Than In … |
